Fusion Analytics for Quality Systems

large novi logo

Enhance Bio/Pharma Operations

Answer difficult questions about your Bio/Pharma operations by unifying and analyzing quantitative and qualitative (text) data from any database or file.


  • Create custom dashboards to draw insights from your data.
  • Aggregate data from multiple disparate data sources and make them act as one dataset.
  • Interact with dynamic visualization tools to filter data to find the answer to your questions.
  • Use powerful natural language processing and machine learning tools to create models to classify and predict outcomes from new data.


  • Easily track batch production records to observe trends that lead to non-compliant drug product.
  • Quickly review change control and validation documents for relevant data necessary for supplemental filings or failure investigations.
  • Enhance training and usability of SOPs by assessing production deviations and extracting relevant data.
  • Determine effectiveness of Corrective and Preventive Actions (CAPAs) by comparing before and after data.


  • Fusion Analytics is sold as a subscription.
  • The subscription includes the software, deployment services, consulting, and support you need to easily begin using Fusion Analytics in your environment.
  • Fusion Analytics does not require any infrastructure or integration activities other than permissions for configuration.
  • There are no limits on the number of users, data connections, or analytics.

“With Fusion Analytics, our organization has taken a more systematic and data driven approach to understanding our deviation trends. Fusion Analytics gives us the ability to quickly identify areas of weakness, and implement appropriate and meaningful actions to help reduce and eliminate deviations across our global manufacturing network. Fusion Analytics has been a real benefit for our quality teams.”

Dr. Matt Wessel

Pharmaceutical Services Group, Thermo Fisher Scientific

The BioPharma Quality Podcast

FDA Data Integration

FDA ViewFinder is a set of Fusion Analytics for Quality Systems dashboards that track FDA activities related to inspections and adverse events.

These dashboards have the following capabilities:

  • Using Natural Language Processing, the system scans PubMed for recent publications regarding adverse events as well as events posted in MedWatch.
  • 483 Filings and Guidance Documents are automatically uploaded and added to the database. This data is evaluated using NLP and Machine Learning for topics applicable to Operations.
  • If a Fusion Analytics subscription is purchased, ViewFinder is included. This allows the user to compare FDA findings with internal deviation reports or other quality system processes.
  • The system also can connect to LIMS systems for in-depth analysis of trends.

My frustration at the inability to gather and analyze data from different development and production systems led to the formation of Fusion Analytics.

Mike Kowolenko, PhD

CEO, NoviSystems, Former Senior Executive - Biogen, Wyeth

FDA ViewFinder Dashboards

The Citations and Classifications dashboard uses aggregated FDA data in an interactive dashboard that allows the user to filter and visualize content based on any combination of categories present in the data as well as using Natural Language Processing and Machine Learning.  These data are valuable in establishing inspection trends.

The system contains Form 483’s obtained from the FDA regarding Drugs and Biologicals.  This includes the commonly requested Form 483’s as well as those obtained by FOIA requests (selected based on OAI).  The system uses Natural Language Processing a well Rules-Based and Machine Learning to select topics of interest with subsequent interactive visualizations.  This dashboard can be filtered by the user using word searches. 

The system allows for the visualization of the 483 as well as abstraction of key phrases and sentences, identification of Inspectors and the citations associated with various inspection teams.

Like the Form 483 dashboard, the system provides an interface for exploring all Drug and Biologics Warning Letters.  The Dashboard was developed using NLP; the user can supplement the filters using term searches.

FDA ViewFinder refreshes its data nightly.  When required, FOIA requests are filed on a monthly basis for all 483’s where OAI is indicated.

This dashboard contains the text for both 210 and 211.  This provides a quick searchable form the regulations to assist in interpreting inspection citations.

The Adverse Events dashboard allows the user to explore the FDA adverse events database in an interactive manner.  Each attribute associated with adverse event reporting is linked so that the user can “drill down” and quickly visualize their results to spot trends.

In addition, the system uses Natural Language Processing to scan recent PubMed abstracts searching for reports of adverse events. Key phrases from the abstracts are displayed in the ViewFinder as well as links to the PubMed abstract.

This dashboard contains over 1600 Guidance documents that can be searched for topics of interest.  This is of particular value when determining or establishing context behind as well as in formulating responses to inspection findings.  The system is also useful when developing protocols or proposals for regulatory review.